Sotagliflozin
EFC14875
Phase 3 small_molecule terminated
Quick answer
Sotagliflozin for Heart Failure is a Phase 3 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- LEXICON PHARMACEUTICALS, INC.
- Indication
- Heart Failure
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated